Viaskin Peanut not checked
DBV Technologies · DBV712
FollowEvery change as it happens, and a Monday email
Trials
2 active
7 in total · 2 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Allergy, Peanut, Allergy, Peanut Allergy
- Main trialPhase 3
- “The primary purpose of this study is to assess the efficacy and safety of daily DBV712 250 micrograms (mcg) to induce desensitization to peanut in peanut-allergic children 4-7 years of age over a 12-month double-blind, placebo-controlled (DBPC) Treatment Period.”In the company’s words, NCT05741476 on ClinicalTrials.gov
- Other names
- DBV712 · ViaskinTM Peanut
Other drugs for Allergy, Peanut
Coming up1
- NovPhase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 6 Nov 2025 | Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age | |
| Phase 3Active, not recruiting | Nov 2026 | Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) | |
| Phase 3Completed | 18 Aug 2017 | Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy | |
| Phase 3Completed | 22 Sep 2017 | Safety Study of Viaskin Peanut to Treat Peanut Allergy | |
| Phase 3Completed | 13 May 2025 | Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children | |
| Phase 2Completed | Jul 2014 | Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy | |
| Phase 2Completed | Sep 2016 | Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026